Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Revlimid in IPSS low/int-1 MDS with del(5q)
NCT01081431Phase 2Completed
- Sponsor
- GMIHO Gesellschaft für Medizinische Innovation - Hämatologie und Onkologie
- Start
- Mar 2010
- Primary completion
- May 2018
- Countries
- 1
01
Overview
A Phase 2 trial of lenalidomide in myelodysplastic syndrome (MDS), sponsored by GMIHO Gesellschaft für Medizinische Innovation - Hämatologie und Onkologie. Started Mar 2010; status: completed.
02
Drugs
lenalidomide
03
Conditions
myelodysplastic syndrome (MDS)
Beyond the preview
Go deeper on NCT01081431.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01081431.